Skip to main content
Erschienen in: Neurocritical Care 3/2008

01.06.2008 | Original Article

The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subarachnoid Hemorrhage

verfasst von: Rajat Dhar, Michael N. Diringer

Erschienen in: Neurocritical Care | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Subarachnoid hemorrhage (SAH) can trigger immune activation sufficient to induce the systemic inflammatory response syndrome (SIRS). This may promote both extra-cerebral organ dysfunction and delayed cerebral ischemia, contributing to worse outcome. We ascertained the frequency and predictors of SIRS after spontaneous SAH, and determined whether degree of early systemic inflammation predicted the occurrence of vasospasm and clinical outcome.

Methods

Retrospective analysis of prospectively collected data on 276 consecutive patients admitted to a neurosciences intensive care unit with acute, non-traumatic SAH between 2002 and 2005. A daily SIRS score was derived by summing the number of variables meeting standard criteria (HR >90, RR >20, Temperature >38°C, or <36°C, WBC count <4,000 or >12,000). SIRS was considered present if two or more criteria were met, while SIRS burden over the first four days was calculated by averaging daily scores. Regression modeling was used to determine the relationship among SIRS burden (after controlling for confounders including infection, surgery, and corticosteroid use), symptomatic vasospasm, and outcome, determined by hospital disposition.

Results

SIRS was present in over half the patients on admission and developed in 85% within the first four days. Factors associated with SIRS included poor clinical grade, thick cisternal blood, larger aneurysm size, higher admission blood pressure, and surgery for aneurysm clipping. Higher SIRS burden was independently associated with death or discharge to nursing home (OR 2.20/point, 95% CI 1.27–3.81). All of those developing clinical vasospasm had evidence of SIRS, with greater SIRS burden predicting increased risk for delayed ischemic neurological deficits (OR 1.77/point, 95% CI 1.12–2.80).

Conclusions

Systemic inflammatory activation is common after SAH even in the absence of infection; it is more frequent in those with more severe hemorrhage and in those who undergo surgical clipping. Higher burden of SIRS in the initial four days independently predicts symptomatic vasospasm and is associated with worse outcome.
Literatur
1.
Zurück zum Zitat Gruber A, Rossler K, Graninger W, Donner A, Illievich U, Czech T. Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000;12:297–306.PubMedCrossRef Gruber A, Rossler K, Graninger W, Donner A, Illievich U, Czech T. Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000;12:297–306.PubMedCrossRef
2.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB, Fein AM, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.PubMedCrossRef Bone RC, Balk RA, Cerra FB, Fein AM, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.PubMedCrossRef
3.
Zurück zum Zitat Napolitano LM, Ferrer T, McCarter RJ Jr, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma 2000;49:647–52; discussion 652–643.PubMed Napolitano LM, Ferrer T, McCarter RJ Jr, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma 2000;49:647–52; discussion 652–643.PubMed
5.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC, Abraham E, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–8.PubMed Levy MM, Fink MP, Marshall JC, Abraham E, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–8.PubMed
6.
Zurück zum Zitat Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765–77.PubMedCrossRef Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765–77.PubMedCrossRef
7.
Zurück zum Zitat Malham GM, Souter MJ. Systemic inflammatory response syndrome and acute neurological disease. Br J Neurosurg 2001;15:381–7.PubMedCrossRef Malham GM, Souter MJ. Systemic inflammatory response syndrome and acute neurological disease. Br J Neurosurg 2001;15:381–7.PubMedCrossRef
8.
Zurück zum Zitat Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen JR. Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery 1992;31:42–51.PubMedCrossRef Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen JR. Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery 1992;31:42–51.PubMedCrossRef
9.
Zurück zum Zitat Naredi S, Lambert G, Eden E, et al. Increased sympathetic nervous system activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000;31:901–6.PubMed Naredi S, Lambert G, Eden E, et al. Increased sympathetic nervous system activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000;31:901–6.PubMed
10.
Zurück zum Zitat Moynihan J, Kruszewska B, Madden K, Callahan T. Sympathetic nervous system regulation of immunity. J Neuroimmunol 2004;147:87–90.PubMedCrossRef Moynihan J, Kruszewska B, Madden K, Callahan T. Sympathetic nervous system regulation of immunity. J Neuroimmunol 2004;147:87–90.PubMedCrossRef
11.
Zurück zum Zitat Gruber A, Reinprecht A, Illievich U, et al. Extracerebral organ dyfsunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999;27:505–14.PubMedCrossRef Gruber A, Reinprecht A, Illievich U, et al. Extracerebral organ dyfsunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999;27:505–14.PubMedCrossRef
12.
Zurück zum Zitat Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001;56:1299–1304.PubMed Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001;56:1299–1304.PubMed
13.
Zurück zum Zitat Parkinson D, Stephenson S. Leukocytosis and subarachnoid hemorrhage. Surg Neurol 1984;21:132–4.PubMedCrossRef Parkinson D, Stephenson S. Leukocytosis and subarachnoid hemorrhage. Surg Neurol 1984;21:132–4.PubMedCrossRef
14.
Zurück zum Zitat Weir B, Disney L, Grace M, Roberts P. Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 1989;25:161–5.PubMedCrossRef Weir B, Disney L, Grace M, Roberts P. Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 1989;25:161–5.PubMedCrossRef
15.
Zurück zum Zitat McGirt MJ, Mavropoulos JC, McGirt LY, et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;98:1222–6.PubMed McGirt MJ, Mavropoulos JC, McGirt LY, et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;98:1222–6.PubMed
16.
Zurück zum Zitat Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001;32:1989–93.PubMedCrossRef Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001;32:1989–93.PubMedCrossRef
17.
Zurück zum Zitat Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003;53:123–35.PubMedCrossRef Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003;53:123–35.PubMedCrossRef
18.
Zurück zum Zitat Hughes JT, Schianchi PM. Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978;48:515–25.PubMed Hughes JT, Schianchi PM. Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978;48:515–25.PubMed
19.
Zurück zum Zitat Fassbender K, Hodapp B, Rossol S, Bertsch T, et al. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000;31:2971–5.PubMed Fassbender K, Hodapp B, Rossol S, Bertsch T, et al. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000;31:2971–5.PubMed
20.
Zurück zum Zitat Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989;20:1021–6.PubMed Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989;20:1021–6.PubMed
21.
Zurück zum Zitat Miller JA, Dacey RG Jr, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995;26:2260–6.PubMed Miller JA, Dacey RG Jr, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995;26:2260–6.PubMed
22.
Zurück zum Zitat Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988;51:1457.PubMed Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988;51:1457.PubMed
23.
Zurück zum Zitat Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9.PubMedCrossRef Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9.PubMedCrossRef
24.
Zurück zum Zitat Hijdra A, Brouwers PJ, Vermeulen M, van Gijn J. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke 1990;21:1156–61.PubMed Hijdra A, Brouwers PJ, Vermeulen M, van Gijn J. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke 1990;21:1156–61.PubMed
25.
Zurück zum Zitat Sebha FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 2006;28:381–98.CrossRef Sebha FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 2006;28:381–98.CrossRef
26.
Zurück zum Zitat Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006;32:1955–61.PubMedCrossRef Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006;32:1955–61.PubMedCrossRef
27.
Zurück zum Zitat McKeating EG, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 1997;78:520–3.PubMed McKeating EG, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 1997;78:520–3.PubMed
28.
Zurück zum Zitat Minambres E, Cemborain A, Sanchez-Velasco P, et al. Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med 2003;31:933–8.PubMedCrossRef Minambres E, Cemborain A, Sanchez-Velasco P, et al. Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med 2003;31:933–8.PubMedCrossRef
29.
Zurück zum Zitat Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.PubMedCrossRef Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.PubMedCrossRef
30.
Zurück zum Zitat Rothoerl RD, Axmann C, Pina A-L, Woertgen C, Brawanksi A. Possible role of C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2006;18:68–72.PubMedCrossRef Rothoerl RD, Axmann C, Pina A-L, Woertgen C, Brawanksi A. Possible role of C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2006;18:68–72.PubMedCrossRef
31.
Zurück zum Zitat de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 2007;30:22–30; discussion 30–21.PubMedCrossRef de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 2007;30:22–30; discussion 30–21.PubMedCrossRef
32.
Zurück zum Zitat Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001;70:534–7.PubMedCrossRef Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001;70:534–7.PubMedCrossRef
33.
Zurück zum Zitat Peterson JW, Kwun BD, Teramura A, et al. Immunological reaction against the aging human subarachnoid erythrocyte. A model for the onset of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1989;71:718–26.PubMed Peterson JW, Kwun BD, Teramura A, et al. Immunological reaction against the aging human subarachnoid erythrocyte. A model for the onset of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1989;71:718–26.PubMed
34.
Zurück zum Zitat Bowton DL, Bertels NH, Prough DS, Stump DA. Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med 1989;17:399–403.PubMedCrossRef Bowton DL, Bertels NH, Prough DS, Stump DA. Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med 1989;17:399–403.PubMedCrossRef
35.
Zurück zum Zitat Suarez JI, Qureshi AI, Yahia AB, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 2002;30:1348–55.PubMedCrossRef Suarez JI, Qureshi AI, Yahia AB, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 2002;30:1348–55.PubMedCrossRef
36.
Zurück zum Zitat O’Connor E, Venkatesh B, Mashongonyika C, Lipman J, Hall J, Thomas P. Serum procalcitonin and c-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care 2004;32:465–70. O’Connor E, Venkatesh B, Mashongonyika C, Lipman J, Hall J, Thomas P. Serum procalcitonin and c-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care 2004;32:465–70.
37.
Zurück zum Zitat Gosling P, Czyz J, Nightingale P, Manji M. Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit Care Med 2006;34:2158–66.PubMedCrossRef Gosling P, Czyz J, Nightingale P, Manji M. Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit Care Med 2006;34:2158–66.PubMedCrossRef
38.
Zurück zum Zitat Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998;29:1930–5; discussion 1935–1936.PubMed Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998;29:1930–5; discussion 1935–1936.PubMed
39.
Zurück zum Zitat Clatterbuck RE, Gailloud P, Ogata L, et al. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 2003;99:376–82.PubMedCrossRef Clatterbuck RE, Gailloud P, Ogata L, et al. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 2003;99:376–82.PubMedCrossRef
40.
Zurück zum Zitat German JW, Gross CE, Giclas P, Watral W, Bednar MM. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 1996;39:141–5; discussion 145–146.PubMedCrossRef German JW, Gross CE, Giclas P, Watral W, Bednar MM. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 1996;39:141–5; discussion 145–146.PubMedCrossRef
41.
Zurück zum Zitat Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005;36:2024–6.PubMedCrossRef Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005;36:2024–6.PubMedCrossRef
42.
Zurück zum Zitat Neil-Dwyer G, Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid hemorrhage. Eur J Clin Pharmacol 1985;28(Suppl):25–9.PubMedCrossRef Neil-Dwyer G, Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid hemorrhage. Eur J Clin Pharmacol 1985;28(Suppl):25–9.PubMedCrossRef
43.
Zurück zum Zitat Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627–32.PubMedCrossRef Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627–32.PubMedCrossRef
44.
Zurück zum Zitat McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002;33:2950–6.PubMedCrossRef McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002;33:2950–6.PubMedCrossRef
45.
Zurück zum Zitat McGirt MJ, Pradilla G, Legnani FG, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 2006;58:945–51; discussion 945–951.PubMedCrossRef McGirt MJ, Pradilla G, Legnani FG, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 2006;58:945–51; discussion 945–951.PubMedCrossRef
46.
Zurück zum Zitat Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006;34:660–7.PubMedCrossRef Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006;34:660–7.PubMedCrossRef
Metadaten
Titel
The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subarachnoid Hemorrhage
verfasst von
Rajat Dhar
Michael N. Diringer
Publikationsdatum
01.06.2008
Verlag
Humana Press Inc
Erschienen in
Neurocritical Care / Ausgabe 3/2008
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-008-9054-2

Weitere Artikel der Ausgabe 3/2008

Neurocritical Care 3/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.